The discovery of new biomarkers is crucial for the advancement of personalized medicine. They can help in identifying cancer at an early stage, determining the aggressiveness of the cancer, and in predicting how well a patient will respond to a specific treatment. This personalized approach can significantly improve patient outcomes.
